These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26999293)

  • 1. Translational atherosclerosis research: From experimental models to coronary artery disease in humans.
    Gleissner CA
    Atherosclerosis; 2016 May; 248():110-6. PubMed ID: 26999293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decorin in atherosclerosis.
    Singla S; Hu C; Mizeracki A; Mehta JL
    Ther Adv Cardiovasc Dis; 2011 Dec; 5(6):305-14. PubMed ID: 22089475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical mouse models and methods for the discovery of the causes and treatments of atherosclerosis.
    Hewing B; Fisher EA
    Expert Opin Drug Discov; 2012 Mar; 7(3):207-16. PubMed ID: 22468952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory therapeutic targets in coronary atherosclerosis-from molecular biology to clinical application.
    Linden F; Domschke G; Erbel C; Akhavanpoor M; Katus HA; Gleissner CA
    Front Physiol; 2014; 5():455. PubMed ID: 25484870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the characteristics of human atherosclerosis: A difficult but indispensable task providing the direction and proof of concept for pioneering atherosclerosis research in animal models.
    Chen YC; Peter K
    Atherosclerosis; 2015 Aug; 241(2):595-6. PubMed ID: 26115071
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary Atherosclerosis: Pathophysiologic Basis for Diagnosis and Management.
    Boudoulas KD; Triposciadis F; Geleris P; Boudoulas H
    Prog Cardiovasc Dis; 2016; 58(6):676-92. PubMed ID: 27091673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Angiogenesis in Coronary Artery Disease: A Double-Edged Sword: Intraplaque Angiogenesis in Physiopathology and Therapeutic Angiogenesis for Treatment.
    Wu W; Li X; Zuo G; Pu J; Wu X; Chen S
    Curr Pharm Des; 2018; 24(4):451-464. PubMed ID: 29283055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large animal models of atherosclerosis--new tools for persistent problems in cardiovascular medicine.
    Shim J; Al-Mashhadi RH; Sørensen CB; Bentzon JF
    J Pathol; 2016 Jan; 238(2):257-66. PubMed ID: 26414760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherosclerotic plaque regression: fact or fiction?
    Shanmugam N; Román-Rego A; Ong P; Kaski JC
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):311-7. PubMed ID: 20549322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic melanoma moves on: translational science in the era of personalized medicine.
    Levesque MP; Cheng PF; Raaijmakers MI; Saltari A; Dummer R
    Cancer Metastasis Rev; 2017 Mar; 36(1):7-21. PubMed ID: 28321632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum heat shock protein 27 levels represent a potential therapeutic target for atherosclerosis: observations from a human cohort and treatment of female mice.
    Seibert TA; Hibbert B; Chen YX; Rayner K; Simard T; Hu T; Cuerrier CM; Zhao X; de Belleroche J; Chow BJ; Hawken S; Wilson KR; O'Brien ER
    J Am Coll Cardiol; 2013 Oct; 62(16):1446-54. PubMed ID: 23764828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.
    Naghavi M; Falk E; Hecht HS; Jamieson MJ; Kaul S; Berman D; Fayad Z; Budoff MJ; Rumberger J; Naqvi TZ; Shaw LJ; Faergeman O; Cohn J; Bahr R; Koenig W; Demirovic J; Arking D; Herrera VL; Badimon J; Goldstein JA; Rudy Y; Airaksinen J; Schwartz RS; Riley WA; Mendes RA; Douglas P; Shah PK;
    Am J Cardiol; 2006 Jul; 98(2A):2H-15H. PubMed ID: 16843744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized Cardiovascular Medicine Today: A Food and Drug Administration/Center for Drug Evaluation and Research Perspective.
    Blaus A; Madabushi R; Pacanowski M; Rose M; Schuck RN; Stockbridge N; Temple R; Unger EF
    Circulation; 2015 Oct; 132(15):1425-32. PubMed ID: 26459078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis.
    Russell JC; Proctor SD
    Cardiovasc Pathol; 2006; 15(6):318-30. PubMed ID: 17113010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revascularization versus medical treatments in stable coronary artery disease: predicting the future of novel drug therapies for stable angina.
    Risos L; Berkenboom G
    J Cardiovasc Pharmacol; 2014 Mar; 63(3):213-7. PubMed ID: 24336013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for translational research in heart failure.
    Lara-Pezzi E; Menasché P; Trouvin JH; Badimón L; Ioannidis JP; Wu JC; Hill JA; Koch WJ; De Felice AF; de Waele P; Steenwinckel V; Hajjar RJ; Zeiher AM
    J Cardiovasc Transl Res; 2015 Feb; 8(1):3-22. PubMed ID: 25604959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive imaging of atherosclerotic vessels by MRI for clinical assessment of the effectiveness of therapy.
    Corti R
    Pharmacol Ther; 2006 Apr; 110(1):57-70. PubMed ID: 16445985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin - a multi-modal marker and mediator in atherosclerotic vascular disease.
    Wolak T
    Atherosclerosis; 2014 Oct; 236(2):327-37. PubMed ID: 25128758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment.
    Matsuzawa Y; Lerman A
    Coron Artery Dis; 2014 Dec; 25(8):713-24. PubMed ID: 25365643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current controversies in PCI pharmacotherapy.
    Giustino G; Mehran R
    Minerva Cardioangiol; 2015 Aug; 63(4):275-96. PubMed ID: 25952130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.